Form 4: Absci Director Karen McGinnis Granted Significant Equity Awards

Absci Corporation's Director, Karen K. McGinnis, was granted 14,500 Restricted Stock Units and 57,400 stock options, aligning her interests with the company's long-term performance.

Summary

• Karen K. McGinnis, a Director of Absci Corp (ABSI), was granted 14,500 shares of Common Stock in the form of Restricted Stock Units (RSUs) on June 11, 2025.
• These RSUs were issued under the Absci Corporation 2021 Stock Option and Incentive Plan and represent the contingent right to receive one share of Common Stock per RSU.
• The RSUs are set to vest and be settled in full on the earlier of the first anniversary of the grant date or the date of the Issuer's next annual meeting of stockholders, contingent on continuous service.
• Additionally, Ms. McGinnis was granted 57,400 stock options with an exercise price of $3.01 per share on June 11, 2025.
• These stock options have an expiration date of June 10, 2035, and will vest and become exercisable in full on the earlier of the first anniversary of the grant date or the date of the Issuer's next annual meeting of stockholders, also subject to continuous service.
• Following these transactions, Karen K. McGinnis beneficially owns 38,320 shares of Common Stock directly and 57,400 derivative securities (stock options) directly.

Sentiment

Score: 6

Explanation: The sentiment is slightly positive as the grant of equity to a director aligns their interests with shareholders and is a standard practice for incentivizing long-term commitment, indicating stability in governance.

Positives

• The grant of Restricted Stock Units (RSUs) and stock options to a director aligns management and board interests with shareholder value creation, as the awards vest based on continued service and potential future stock performance.
• The equity grants are part of the company's 2021 Stock Option and Incentive Plan, indicating a structured approach to executive and director compensation designed to incentivize long-term commitment.

Future Outlook

The granted RSUs and stock options are subject to vesting conditions, which include the earlier of the first anniversary of the grant date or the date of the Issuer's next annual meeting of stockholders, contingent on the reporting person's continuous service to the Issuer. This indicates a forward-looking incentive structure tied to continued engagement.

Industry Context

This Form 4 filing is a routine disclosure of an insider transaction, specifically an equity grant to a director. Such grants are common practice across industries, including the biotechnology sector where Absci operates, as a means of compensating and incentivizing board members and executives.

Corporate Governance

Related Party Transactions

• The transaction involves the grant of equity awards (Restricted Stock Units and stock options) by Absci Corporation to Karen K. McGinnis, a director of the company, which constitutes a related party transaction.

Stakeholder Impact

• Shareholders: The grant of equity awards may result in minor dilution upon vesting and exercise, but it also aims to align the director's interests with shareholder value creation, potentially leading to better long-term performance.
• Employees: While this specific transaction is for a director, the underlying incentive plan (2021 Stock Option and Incentive Plan) may also apply to employees, indicating a broader compensation strategy.

Next Steps

• The Restricted Stock Units (RSUs) and stock options will vest on the earlier of the first anniversary of the grant date (June 11, 2026) or the date of Absci Corporation's next annual meeting of stockholders, subject to Karen K. McGinnis's continuous service.

Key Dates

Keywords

SEC Form 4, Absci Corp, ABSI, Restricted Stock Units, RSUs, Stock Options, Insider Transaction, Equity Grant, Director Compensation, Corporate Governance